These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7947885)

  • 1. Reversal of donor myocardial dysfunction by triiodothyronine replacement therapy.
    Jeevanandam V; Todd B; Regillo T; Hellman S; Eldridge C; McClurken J
    J Heart Lung Transplant; 1994; 13(4):681-7; discussion 685-7. PubMed ID: 7947885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. University of Wisconsin solution versus crystalloid cardioplegia for human donor heart preservation. A randomized blinded prospective clinical trial.
    Jeevanandam V; Barr ML; Auteri JS; Sanchez JA; Fong J; Schenkel FA; Marboe CC; Michler RE; Smith CR; Rose EA
    J Thorac Cardiovasc Surg; 1992 Feb; 103(2):194-8; discussion 198-9. PubMed ID: 1735983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of intracellular solutions for donor heart preservation.
    Hendry PJ; Labow RS; Keon WJ
    J Thorac Cardiovasc Surg; 1993 Apr; 105(4):667-73. PubMed ID: 8469000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incomplete recovery of working heart function after twenty-four-hour preservation with a modified University of Wisconsin solution.
    Smolens IA; Follette DM; Berkoff HA; Castellanos LM; Segel LD
    J Heart Lung Transplant; 1995; 14(5):906-15. PubMed ID: 8800727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of myocardial function in orthotopic cardiac allografts after prolonged storage in UW solution.
    Elbeery JR; Lucke JC; Speier R; Rankin JS; VanTrigt P
    J Heart Lung Transplant; 1991; 10(4):527-36. PubMed ID: 1911795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of hypothermic heart preservation with University of Wisconsin solution in heterotopically and orthotopically transplanted canine hearts.
    Mori Y; Hirose H; Murakawa S; Yamada T; Ishikawa M
    J Heart Lung Transplant; 1994; 13(4):688-950. PubMed ID: 7947886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of calcium concentration, lactobionate content, and sodium/ potassium ratio of preservation solutions on resting left ventricular pressure and postreperfusion function of rabbit heterotopic heart transplants.
    Termignon JL; Pradier F; Petit A; Journois D; Weiss M; Mazmanian M
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1126-35. PubMed ID: 8719460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of University of Wisconsin solution on clinical heart transplantation. A comparison with Stanford solution for extended preservation.
    Stringham JC; Love RB; Welter D; Canver CC; Mentzer RM
    Circulation; 1998 Nov; 98(19 Suppl):II157-61; discussion II162. PubMed ID: 9852898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recovery of nonbeating donor hearts.
    Illes RW; Asimakis GK; Inners-McBride K; Buckingham ED
    J Heart Lung Transplant; 1995; 14(3):553-61. PubMed ID: 7654739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organ procurement using abdominal cavity cooling after management of the brain dead donor: an experimental study.
    Toda R; Nishimura A; Matsunaga Y; Yamashita T; Moriyama Y; Saigenji H; Kamimura R; Taira A
    Transplant Proc; 1993 Dec; 25(6):3162-4. PubMed ID: 8266500
    [No Abstract]   [Full Text] [Related]  

  • 11. Lung retrieval from cadaver donors with nonbeating hearts: optimal preservation solution.
    D'Armini AM; Roberts CS; Lemasters JJ; Egan TM
    J Heart Lung Transplant; 1996 May; 15(5):496-505. PubMed ID: 8771505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming the "unacceptable" donor: outcomes from the adoption of a standardized donor management technique.
    Wheeldon DR; Potter CD; Oduro A; Wallwork J; Large SR
    J Heart Lung Transplant; 1995; 14(4):734-42. PubMed ID: 7578183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of Ca++ on the preservation of myocardial energy and function with University of Wisconsin solution. A 31P nuclear magnetic resonance study of isolated blood perfused Langendorff pig hearts.
    Tian G; Biro GP; Butler KW; Xiang B; Vu C; Deslauriers R
    J Heart Lung Transplant; 1993; 12(1 Pt 1):81-8. PubMed ID: 8443206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretreatment of donors with endothelin receptor antagonist TAK-044 improves cardiac functional recovery following preservation with University of Wisconsin solution.
    Kaneda T; Zhang ZW; Ogawa T; Otaki M; Saga T
    Scand Cardiovasc J; 2002 Mar; 36(2):105-7. PubMed ID: 12028874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type of donor aortic preservation solution and not cold ischemia time is a major determinant of biliary strictures after liver transplantation.
    Pirenne J; Van Gelder F; Coosemans W; Aerts R; Gunson B; Koshiba T; Fourneau I; Mirza D; Van Steenbergen W; Fevery J; Nevens F; McMaster P
    Liver Transpl; 2001 Jun; 7(6):540-5. PubMed ID: 11443584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenine nucleotide content in cold preserved human donor hearts and subsequent cardiac performance after orthotopic heart transplantation.
    Starling RC; Hammer DF; Binkley PF; Galbraith TA; Howanitz EP; Murray KD; Watson KM; Myerowitz PD
    J Heart Lung Transplant; 1991; 10(4):508-16; discussion 517. PubMed ID: 1911793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clinical trial of University of Wisconsin solution for pulmonary preservation.
    Hardesty RL; Aeba R; Armitage JM; Kormos RL; Griffith BP
    J Thorac Cardiovasc Surg; 1993 Apr; 105(4):660-6. PubMed ID: 8468999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinical trial comparing University of Wisconsin solution and cold cardioplegic solution with load-independent mechanical parameters.
    Kawai A; Morita S; Kormos RL; Mandarino WA; Gasior TA; Pham SM; Armitage JM; Hardesty RL; Griffith BP
    J Heart Lung Transplant; 1994; 13(1 Pt 1):150-5; discussion 155-6. PubMed ID: 8167121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A lactobionate-based extracellular-type solution for donor heart preservation.
    Shiiya N; Paul M; Benvenuti C; Astier A; Ferrer MJ; Loisance D
    J Heart Lung Transplant; 1993; 12(3):476-83. PubMed ID: 8329421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organ preservation with histidine-tryptophan ketogluatarate solution in clinical pancreas transplantation: an update of the indiana university experience.
    Agarwal A; Powelson JA; Goggins WC; Milgrom ML; Fridell JA
    Transplant Proc; 2008 Mar; 40(2):498-501. PubMed ID: 18374113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.